[PDF][PDF] DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy

MM Awad, D Dalal, E Cho, N Amat-Alarcon… - The American Journal of …, 2006 - cell.com
MM Awad, D Dalal, E Cho, N Amat-Alarcon, C James, C Tichnell, A Tucker, SD Russell…
The American Journal of Human Genetics, 2006cell.com
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a disorder
characterized by fibrofatty replacement of cardiac myocytes that typically manifests in the
right ventricle. It is inherited as an autosomal dominant disease with reduced penetrance,
although autosomal recessive forms of the disease also occur. We identified four probands
with ARVD/C caused by mutations in DSG2, which encodes desmoglein-2, a component of
the cardiac desmosome. No association between mutations in this gene and human disease …
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a disorder characterized by fibrofatty replacement of cardiac myocytes that typically manifests in the right ventricle. It is inherited as an autosomal dominant disease with reduced penetrance, although autosomal recessive forms of the disease also occur. We identified four probands with ARVD/C caused by mutations in DSG2, which encodes desmoglein-2, a component of the cardiac desmosome. No association between mutations in this gene and human disease has been reported elsewhere. One of these probands has compound-heterozygous mutations in DSG2, and the remaining three have isolated heterozygous missense mutations, each disrupting known functional components of desmoglein-2. We report that mutations in DSG2 contribute to the development of ARVD/C.
cell.com